← Back to Clinical Trials
Recruiting Phase 4 NCT06958588

Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis

Trial Parameters

Condition Venous Thromboembolism (VTE)
Sponsor Science Valley Research Institute
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 50
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2025-05-25
Completion 2025-12-20
Interventions
Experimental: HyperslimActive Comparator #1

Brief Summary

Venous thromboembolism (VTE) is frequent in patients in the intensive care unit (ICU). Pharmacologic prophylaxis is sometimes contraindicated, and mechanical prophylaxis is used. The primary objective of the study is to compare Pulsed Electromagnetic Field Therapy (PEMF) with conventional mechanical prophylaxis for the prevention of VTE in patients in the ICU.

Eligibility Criteria

Inclusion Criteria: 1. Patients \> 18 years old in ICU 2. PADUA score\> 4 (medical patients) and/or Caprini score\> 3 (surgical patients) 3. Contraindication to pharmacological prophylaxis or indication to combined (pharmacological and mechanical VTE prophylaxis) Exclusion Criteria: 1. Patients \< 18 years old in ICU 2. Unable to use mechanical prophylaxis due to trauma, burns, fracture, or problems in inferior members that prevent the use of mechanical prophylaxis 3. Life expectations less than 24 hours

Related Trials